Clincosm LogoSign in Get a demo

Lymphoma

Showing NaN - NaN of 239
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial in Worldwide (CC-220, Rituximab, Obinutuzumab)

Recruiting
  • Lymphoma
  • Phoenix, Arizona
  • +36 more
Jul 28, 2022

Large B-cell Lymphoma, Lymphoma Trial in Houston (Loncastuximab Tesirine)

Not yet recruiting
  • Large B-cell Lymphoma
  • Lymphoma
  • Loncastuximab Tesirine
  • Houston, Texas
    MD Anderson Cancer Center
Jul 14, 2022

Lymphoma Trial in Houston (Molecular Functional Portrait)

Recruiting
  • Lymphoma
  • Molecular Functional Portrait
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma Trial in Worldwide (BMS-986403, Fludarabine, Cyclophosphamide)

Recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma
  • Birmingham, Alabama
  • +24 more
Jul 6, 2022

Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

Recruiting
  • Hodgkin's Disease
  • +3 more
  • EBV-specific T cells: A
  • EBV-specific T cells: B
  • Houston, Texas
  • +1 more
Jun 28, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Leukemia, Brain Tumor, Solid Tumor Trial in United States (ALRN-6924, Cytarabine)

Recruiting
  • Leukemia
  • +3 more
  • San Francisco, California
  • +3 more
Jun 14, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

Recruiting
  • Acute Myeloid Leukemia
  • +12 more
  • Los Angeles, California
  • +6 more
Jun 1, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Advanced Solid Tumors, Lymphoma, Multiple Myeloma Trial in Nashville, Houston (AZD0466)

Terminated
  • Advanced Solid Tumors
  • +3 more
  • Nashville, Tennessee
  • +1 more
Apr 22, 2022

Lymphoma, Lymphoma, B-Cell, Leukemia Trial in Houston (Digital Health Coaching)

Recruiting
  • Lymphoma
  • +6 more
  • Digital Health Coaching
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Apr 12, 2022

Solid Tumor, Adult, Lymphoma Trial in Korea, Republic of, Spain, United States (Fadraciclib)

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • Duarte, California
  • +3 more
Apr 1, 2022

Lymphoma, Acute Lymphoblastic Leukemia Trial in Worldwide (Apixaban, No systemic anticoagulant prophylaxis)

Completed
Has Results
  • Lymphoma
  • Acute Lymphoblastic Leukemia
  • Apixaban
  • No systemic anticoagulant prophylaxis
  • Phoenix, Arizona
  • +95 more
Feb 10, 2022

Lymphoma Trial in Houston (2CdA, Cyclophosphamide, Rituximab)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2022

Solid Tumors, Lymphoma Trial in Valhalla, Charlotte, Houston (Eflapegrastim, Chemotherapy)

Recruiting
  • Solid Tumors
  • Lymphoma
  • Valhalla, New York
  • +3 more
Feb 28, 2022

Breast Tumor, Colorectal Tumor, Female Reproductive System Tumor Trial in Houston (Best Practice, Educational Intervention,

Active, not recruiting
  • Breast Neoplasm
  • +5 more
  • Best Practice
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (Durvalumab, Lenalidomide, Rituximab)

Active, not recruiting
Has Results
  • Lymphoma
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Gilbert, Arizona
  • +53 more
Jan 25, 2022

Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

Recruiting
  • Lymphoma
  • +2 more
  • Kappa CD28 T cells
  • Houston, Texas
  • +1 more
Jan 31, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Cancer Fatigue Trial in Houston

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Cognitive Behavior Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 13, 2022

Lymphoma Trial in Worldwide (Nivolumab)

Completed
Has Results
  • Lymphoma
  • Phoenix, Arizona
  • +44 more
Dec 13, 2021

Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)

Active, not recruiting
  • Lymphoma
  • +3 more
  • TGFbeta resistant LMP-specific CTLs
  • Houston, Texas
  • +1 more
Dec 8, 2021

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
Oct 25, 2021

Development ofVideo Game for Improvement of Outcomes in Stem

Recruiting
  • Leukemia
  • Lymphoma
  • Focus Group
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 19, 2021

Long-term, Non-interventional, Observational Study Following

Recruiting
  • Advanced Solid Tumor
  • +17 more
  • Allogeneic natural killer (NK) cell
  • San Diego, California
  • +3 more
Oct 15, 2021